Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROP2 CAR/IL-15 TGFBR2 KO NK Cells in Gastric Cancer Metastatic to the Peritoneum
NCT07509008Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2026
- Primary completion
- Jul 2028
- Modality
- Gene Editing, Gene Silencing, Lymphokine-Activated Killer Cells
- Countries
- 1
01
Overview
A Phase 2 trial of TGFBR2 KO CAR.70/IL-15 NK cells in gastric cancer (GC), sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2026; status: recruiting.
02
Drugs
TGFBR2 KO CAR.70/IL-15 NK cells
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07509008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07509008.